1. Home
  2. Analysis

Endometriosis and drugs of ingredients of tocilizumab (a real world drug study)


Summary:

Endometriosis is found among people who take drugs with ingredients of tocilizumab, especially for people who are female, 40-49 old , have been taking the drugs for 1 - 2 years. This phase IV clinical study is created by eHealthMe based on reports of 129,050 people who have side effects when taking drugs with ingredients of tocilizumab from the FDA, and is updated regularly.

Drug(s) considered in the study (i.e. both brand name and generic drugs): Actemra.

On Jun, 14, 2026

129,050 people reported to have side effects when taking drugs with ingredients of tocilizumab.
Among them, 46 people (0.04%) have Endometriosis

What is Endometriosis?

Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain) is found to be associated with 423 drugs and 561 conditions by eHealthMe. Check the latest studies of Endometriosis.

Number of reports submitted per year:

Could drugs with ingredients of tocilizumab cause Endometriosis?

Time on drugs with ingredients of tocilizumab when people have Endometriosis *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 96.43 %
  • 2 - 5 years: 3.5700000000000003 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Endometriosis when taking drugs with ingredients of tocilizumab *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Endometriosis when taking drugs with ingredients of tocilizumab *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 28.57 %
  • 30-39: 14.29 %
  • 40-49: 42.86 %
  • 50-59: 7.14 %
  • 60+: 7.14 %

Conditions people have *:

You may use this to check any potential undetected conditions.

  1. Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 1 person, 2.17%
  2. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 2.17%
  3. Hyperthyroidism (over activity of the thyroid gland): 1 person, 2.17%
  4. Heart Disease: 1 person, 2.17%

Other drugs people take *:

You may use this to check any potential interacting drugs.

  1. Simponi: 27 people, 58.70%
  2. Humira: 27 people, 58.70%
  3. Methotrexate: 26 people, 56.52%
  4. Cimzia: 18 people, 39.13%
  5. Benadryl: 6 people, 13.04%
  6. Synthroid: 6 people, 13.04%
  7. Valacyclovir: 5 people, 10.87%
  8. Methotrexate Sodium: 4 people, 8.70%
  9. Tylenol: 4 people, 8.70%
  10. Aspirin: 3 people, 6.52%

Other side effects people have besides Endometriosis *:

You may use this to check any potential undetected side effects.

  1. Menometrorrhagia (a condition in which prolonged or excessive uterine bleeding occurs irregularly and more frequently than normal): 27 people, 58.70%
  2. Neck Pain: 27 people, 58.70%
  3. Joint Pain: 27 people, 58.70%
  4. Weight Decreased: 6 people, 13.04%
  5. C-Reactive Protein Increased: 6 people, 13.04%
  6. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 6 people, 13.04%
  7. Dizziness: 6 people, 13.04%
  8. Drowsiness: 6 people, 13.04%
  9. Drug Ineffective: 6 people, 13.04%
  10. Fatigue (feeling of tiredness): 6 people, 13.04%

* Approximation only. Some reports may have incomplete information.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drugs with ingredients of tocilizumab, their effectiveness, alternatives and more:

How the study uses the data?

The study uses data from the FDA. It is based on tocilizumab. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.